treatment: be for lymphoma determined

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents regimen
Weight: 0.66
, surgery
Weight: 0.62
, protocol
Weight: 0.59
, matter
Weight: 0.58
Siblings gene therapy
Weight: 0.72
, dialysis
Weight: 0.70
, blood transfusion
Weight: 0.70
, aspirin
Weight: 0.67

Related properties

Property Similarity
be for lymphoma determined 1.00
be for lymphoma 0.97
be given to cancer patients 0.82
help lung cancer 0.81
prevent cancer 0.79
be used in kawasaki disease 0.78
be option with cancers 0.78
reduce cancer risk 0.76
be needed during chemo 0.76
be for illness important 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.50
Rule weight: 0.66
Evidence weight: 0.92
Similarity weight: 0.81
Evidence: 0.91
Plausible(surgery, help lung cancer) ⋁
Evidence: 0.98
¬ Typical(treatment, be for lymphoma determined)
0.38
Rule weight: 0.66
Evidence weight: 0.74
Similarity weight: 0.78
Evidence: 0.73
Plausible(surgery, be option with cancers) ⋁
Evidence: 0.98
¬ Typical(treatment, be for lymphoma determined)

Plausibility inheritance from parent to child

0.07
Rule weight: 0.09
Evidence weight: 0.93
Similarity weight: 0.81
Evidence: 0.93
Plausible(treatment, be for lymphoma determined) ⋁
Evidence: 0.91
¬ Plausible(surgery, help lung cancer)
0.07
Rule weight: 0.09
Evidence weight: 0.95
Similarity weight: 0.78
Evidence: 0.93
Plausible(treatment, be for lymphoma determined) ⋁
Evidence: 0.73
¬ Plausible(surgery, be option with cancers)

Remarkability exclusitivity betweem a parent and a child

0.35
Rule weight: 0.58
Evidence weight: 0.75
Similarity weight: 0.81
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.50
¬ Remarkable(surgery, help lung cancer)
0.32
Rule weight: 0.58
Evidence weight: 0.71
Similarity weight: 0.78
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.58
¬ Remarkable(surgery, be option with cancers)

Remarkability exclusitivity between siblings

0.08
Rule weight: 0.13
Evidence weight: 0.81
Similarity weight: 0.78
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.38
¬ Remarkable(aspirin, be used in kawasaki disease)
0.08
Rule weight: 0.13
Evidence weight: 0.73
Similarity weight: 0.82
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.53
¬ Remarkable(blood transfusion, be given to cancer patients)
0.08
Rule weight: 0.13
Evidence weight: 0.78
Similarity weight: 0.76
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.44
¬ Remarkable(aspirin, reduce cancer risk)
0.08
Rule weight: 0.13
Evidence weight: 0.73
Similarity weight: 0.79
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.53
¬ Remarkable(aspirin, prevent cancer)
0.06
Rule weight: 0.13
Evidence weight: 0.64
Similarity weight: 0.76
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.70
¬ Remarkable(blood transfusion, be needed during chemo)

Remarkability from parent implausibility

0.33
Rule weight: 0.42
Evidence weight: 0.96
Similarity weight: 0.81
Evidence: 0.91
Plausible(surgery, help lung cancer) ⋁
Evidence: 0.51
Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.93
¬ Plausible(treatment, be for lymphoma determined)
0.29
Rule weight: 0.42
Evidence weight: 0.88
Similarity weight: 0.78
Evidence: 0.73
Plausible(surgery, be option with cancers) ⋁
Evidence: 0.51
Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.93
¬ Plausible(treatment, be for lymphoma determined)

Remarkability from sibling implausibility

0.48
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.82
Evidence: 0.93
Plausible(treatment, be for lymphoma determined) ⋁
Evidence: 0.53
Remarkable(blood transfusion, be given to cancer patients) ⋁
Evidence: 0.94
¬ Plausible(blood transfusion, be given to cancer patients)
0.46
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.79
Evidence: 0.93
Plausible(treatment, be for lymphoma determined) ⋁
Evidence: 0.53
Remarkable(aspirin, prevent cancer) ⋁
Evidence: 0.89
¬ Plausible(aspirin, prevent cancer)
0.45
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.78
Evidence: 0.93
Plausible(treatment, be for lymphoma determined) ⋁
Evidence: 0.38
Remarkable(aspirin, be used in kawasaki disease) ⋁
Evidence: 0.64
¬ Plausible(aspirin, be used in kawasaki disease)
0.45
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.76
Evidence: 0.93
Plausible(treatment, be for lymphoma determined) ⋁
Evidence: 0.70
Remarkable(blood transfusion, be needed during chemo) ⋁
Evidence: 0.88
¬ Plausible(blood transfusion, be needed during chemo)
0.44
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.76
Evidence: 0.93
Plausible(treatment, be for lymphoma determined) ⋁
Evidence: 0.44
Remarkable(aspirin, reduce cancer risk) ⋁
Evidence: 0.88
¬ Plausible(aspirin, reduce cancer risk)

Salient implies Plausible

0.26
Rule weight: 0.28
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.93
Plausible(treatment, be for lymphoma determined) ⋁
Evidence: 0.96
¬ Salient(treatment, be for lymphoma determined)

Similarity expansion

0.81
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.97
Evidence: 0.98
Typical(treatment, be for lymphoma determined) ⋁
Evidence: 0.96
¬ Typical(treatment, be for lymphoma)
0.79
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.97
Evidence: 0.96
Salient(treatment, be for lymphoma determined) ⋁
Evidence: 0.93
¬ Salient(treatment, be for lymphoma)
0.77
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.97
Evidence: 0.93
Plausible(treatment, be for lymphoma determined) ⋁
Evidence: 0.91
¬ Plausible(treatment, be for lymphoma)
0.64
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.76
Evidence: 0.98
Typical(treatment, be for lymphoma determined) ⋁
Evidence: 0.67
¬ Typical(treatment, be for illness important)
0.62
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.97
Evidence: 0.51
Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma)
...

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.98
Similarity weight: 1.00
Evidence: 0.96
Salient(treatment, be for lymphoma determined) ⋁
Evidence: 0.98
¬ Typical(treatment, be for lymphoma determined) ⋁
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined)

Typical implies Plausible

0.45
Rule weight: 0.48
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.93
Plausible(treatment, be for lymphoma determined) ⋁
Evidence: 0.98
¬ Typical(treatment, be for lymphoma determined)

Typicality and Rermarkability incompatibility between a parent and a child

0.24
Rule weight: 0.51
Evidence weight: 0.60
Similarity weight: 0.78
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.79
¬ Typical(surgery, be option with cancers)
0.21
Rule weight: 0.51
Evidence weight: 0.51
Similarity weight: 0.81
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.97
¬ Typical(surgery, help lung cancer)

Typicality and Rermarkability incompatibility between siblings

0.06
Rule weight: 0.14
Evidence weight: 0.60
Similarity weight: 0.78
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.78
¬ Typical(aspirin, be used in kawasaki disease)
0.06
Rule weight: 0.14
Evidence weight: 0.55
Similarity weight: 0.76
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.89
¬ Typical(blood transfusion, be needed during chemo)
0.06
Rule weight: 0.14
Evidence weight: 0.52
Similarity weight: 0.79
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.95
¬ Typical(aspirin, prevent cancer)
0.06
Rule weight: 0.14
Evidence weight: 0.50
Similarity weight: 0.82
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.99
¬ Typical(blood transfusion, be given to cancer patients)
0.05
Rule weight: 0.14
Evidence weight: 0.51
Similarity weight: 0.76
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined) ⋁
Evidence: 0.96
¬ Typical(aspirin, reduce cancer risk)

Typicality inheritance from parent to child

0.39
Rule weight: 0.48
Evidence weight: 0.98
Similarity weight: 0.81
Evidence: 0.98
Typical(treatment, be for lymphoma determined) ⋁
Evidence: 0.97
¬ Typical(surgery, help lung cancer)
0.37
Rule weight: 0.48
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.98
Typical(treatment, be for lymphoma determined) ⋁
Evidence: 0.79
¬ Typical(surgery, be option with cancers)